Works matching AU Pong, Annpey

Results: 37

Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies.

Published in:

Diabetes & Vascular Disease Research, 2019, v. 16, n. 5, p. 415, doi. 10.1177/1479164119842513

By:

Liu, Jie;
Tarasenko, Lisa;
Terra, Steven G;
Huyck, Susan;
Wu, Larry;
Pong, Annpey;
Calle, Roberto A;
Gallo, Silvina;
Darekar, Amanda;
Mancuso, James P

Publication type:

Article

Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trial.

Published in:

2018

By:

Weinstein, Cindy;
Pong, Annpey;
Jordan, Karin;
Green, Stuart A.;
Beckford-Brathwaite, Elizabeth;
Camacho, Elber;
Khanani, Saleem;
Noga, Stephen J.;
Rapoport, Bernardo L.

Publication type:

journal article

Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials.

Published in:

Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0856-7

By:

Liu, Jie;
Pong, Annpey;
Gallo, Silvina;
Darekar, Amanda;
Terra, Steven G.

Publication type:

Article

Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter].

Published in:

2022

By:

Cherney, David Z. I.;
Charbonnel, Bernard;
Cosentino, Francesco;
Dagogo-Jack, Samuel;
McGuire, Darren K.;
Pratley, Richard;
Shih, Weichung J.;
Frederich, Robert;
Maldonado, Mario;
Pong, Annpey;
Cannon, Christopher P.

Publication type:

Letter

Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial.

Published in:

Diabetologia, 2021, v. 64, n. 6, p. 1256, doi. 10.1007/s00125-021-05407-5

By:

Cherney, David Z. I.;
Charbonnel, Bernard;
Cosentino, Francesco;
Dagogo-Jack, Samuel;
McGuire, Darren K.;
Pratley, Richard;
Shih, Weichung J.;
Frederich, Robert;
Maldonado, Mario;
Pong, Annpey;
Cannon, Christopher P.

Publication type:

Article

Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials.

Published in:

Diabetologia, 2020, v. 63, n. 6, p. 1128, doi. 10.1007/s00125-020-05133-4

By:

Cherney, David Z. I.;
Heerspink, Hiddo J. L.;
Frederich, Robert;
Maldonado, Mario;
Liu, Jie;
Pong, Annpey;
Xu, Zhi J.;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

Article

796-P: Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-796-P

By:

CHERNEY, DAVID;
COSENTINO, FRANCESCO;
MCGUIRE, DARREN K.;
CHARBONNEL, BERNARD;
DAGOGO-JACK, SAMUEL;
PRATLEY, RICHARD E.;
SHIH, WEICHUNG J.;
MALDONADO, MARIO;
PONG, ANNPEY;
GANTZ, IRA;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
MASIUKIEWICZ, URSZULA;
CANNON, CHRISTOPHER P.

Publication type:

Article

783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-783-P

By:

CHARBONNEL, BERNARD;
DAGOGO-JACK, SAMUEL;
CANNON, CHRISTOPHER P.;
CHERNEY, DAVID;
COSENTINO, FRANCESCO;
MCGUIRE, DARREN K.;
SHIH, WEICHUNG J.;
LIU, JIE;
PONG, ANNPEY;
GANTZ, IRA;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
PRATLEY, RICHARD E.

Publication type:

Article

1197-P: Two-Year Effects of Ertugliflozin on Renal Function.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1197-P

By:

CHERNEY, DAVID;
HEERSPINK, HIDDO L.;
FREDERICH, ROBERT;
MALDONADO, MARIO;
PONG, ANNPEY;
XU, ZHI JIN;
LIU, JIE;
MANCUSO, JAMES P.;
GANTZ, IRA;
TERRA, STEVEN G.

Publication type:

Article

1188-P: Glycemic Efficacy of Sitagliptin in East Asian Populations: A Pooled Analysis.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1188-P

By:

CONCEICAO, JOAO M.;
GONZALEZ, CLAUDIO D.;
ENGEL, SAMUEL S.;
AHN, JONGHO;
TOKITA, SHIGERU;
ZHANG, YE;
ZHANG, RUYA;
LAM, RAYMOND L.;
PONG, ANNPEY

Publication type:

Article

1153-P: Changes Observed during the Screening Period in Patients Enrolled in the Sitagliptin Clinical Study MK-0431-P083.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1153-P

By:

ROSARIO, CARMEN A.;
JALALUDIN, MUHAMMAD Y.;
GARCIA, RAYMUNDO;
NEWFIELD, RON S.;
SAMOILOVA, YULIA;
SHEHADEH, NAIM;
PONG, ANNPEY;
ZILLI, MARTINA;
SAHA, CHANDAN K.;
ENGEL, SAMUEL S.;
ZEITLER, PHILIP;
KAUFMAN, KEITH D.;
SHANKAR, R. RAVI

Publication type:

Article

2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM).

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2353-PUB

By:

LIU, JIE;
TARASENKO, LISA;
ELLISON, MISOO C.;
PONG, ANNPEY;
HUYCK, SUSAN;
MANCUSO, JAMES P.;
TERRA, STEVEN G.;
GANTZ, IRA

Publication type:

Article

Book Review.

Published in:

2013

By:

Pong, Annpey

Publication type:

Book Review

Guest-Editor's Note: "Statistical Issues in Adaptive Design Methods in Clinical Trials".

Published in:

Journal of Biopharmaceutical Statistics, 2007, v. 17, n. 6, p. 1133, doi. 10.1080/10543400701645199

By:

Pong, Annpey

Publication type:

Article

Adaptive Design in Clinical Research: Issues, Opportunities, and Recommendations.

Published in:

Journal of Biopharmaceutical Statistics, 2006, v. 16, n. 3, p. 299, doi. 10.1080/10543400600609718

By:

Chang, Mark;
Chow, Shein-Chung;
Pong, Annpey

Publication type:

Article

Statistical Consideration of Adaptive Methods in Clinical Development.

Published in:

Journal of Biopharmaceutical Statistics, 2005, v. 15, n. 4, p. 575, doi. 10.1081/BIP-200062277

By:

Chow, Shein-Chung;
Chang, Mark;
Pong, Annpey

Publication type:

Article

Rank Regression in Stability Analysis.

Published in:

Journal of Biopharmaceutical Statistics, 2003, v. 13, n. 3, p. 463, doi. 10.1081/BIP-120022767

By:

Chen, YingQing;
Pong, Annpey;
Xing, Biao

Publication type:

Article

COMPARING DISTRIBUTIONS OF SHELF LIVES FOR DRUG PRODUCTS WITH TWO COMPONENTS UNDER DIFFERENT DESIGNS.

Published in:

Journal of Biopharmaceutical Statistics, 2002, v. 12, n. 3, p. 277, doi. 10.1081/BIP-120014559

By:

Pong, Annpey;
Raghavarao, Damaraju

Publication type:

Article

COMPARISON OF BRACKETING AND MATRIXING DESIGNS FOR A TWO-YEAR STABILITY STUDY.

Published in:

Journal of Biopharmaceutical Statistics, 2000, v. 10, n. 2, p. 217, doi. 10.1081/BIP-100101023

By:

Pong, Annpey;
Raghavarao, Damaraju

Publication type:

Article

Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus.

Published in:

2020

By:

Heymsfield, Steven B.;
Raji, Annaswamy;
Gallo, Silvina;
Liu, Jie;
Pong, Annpey;
Hannachi, Hakima;
Terra, Steven G.

Publication type:

journal article

Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus.

Published in:

2020

By:

Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Huyck, Susan;
Wu, Larry;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

journal article

Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus.

Published in:

2020

By:

Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Huyck, Susan;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Ellison, Misoo C.;
Gantz, Ira;
Terra, Steven G.

Publication type:

journal article

Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References.

Published in:

Biologics: Targets & Therapy, 2024, v. 18, p. 377, doi. 10.2147/BTT.S470182

By:

Pong, Annpey;
Chow, Susan S;
Chow, Shein-Chung

Publication type:

Article

Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.

Published in:

American Journal of Nephrology, 2022, v. 53, n. 7, p. 516, doi. 10.1159/000524889

By:

Cherney, David Z.I.;
Cosentino, Francesco;
Dagogo-Jack, Samuel;
McGuire, Darren K.;
Pratley, Richard E.;
Frederich, Robert;
Maldonado, Mario;
Liu, Chih-Chin;
Pong, Annpey;
Cannon, Christopher P.

Publication type:

Article

Erratum to: Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis.

Published in:

2014

By:

Roux, Christian;
Binkley, Neil;
Boonen, Steven;
Kiel, Douglas;
Ralston, Stuart;
Reginster, Jean-Yves;
Pong, Annpey;
Rosenberg, Elizabeth;
Santora, Arthur

Publication type:

Correction Notice

Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis.

Published in:

Calcified Tissue International, 2014, v. 94, n. 2, p. 153, doi. 10.1007/s00223-013-9763-1

By:

Roux, Christian;
Binkley, Neil;
Boonen, Steven;
Kiel, Douglas;
Ralston, Stuart;
Regnister, Jean-Yves;
Pong, Annpey;
Rosenberg, Elizabeth;
Santora, Arthur

Publication type:

Article

Novel Design and Analysis for Rare Disease Drug Development.

Published in:

Mathematics (2227-7390), 2024, v. 12, n. 5, p. 631, doi. 10.3390/math12050631

By:

Chow, Shein Chung;
Pong, Annpey;
Chow, Susan S.

Publication type:

Article

Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 758, doi. 10.1111/dom.14923

By:

Corbin, Karen D.;
Dagogo‐Jack, Samuel;
Cannon, Christopher P.;
Cherney, David Z.I.;
Cosentino, Francesco;
Frederich, Robert;
Liu, Jie;
Pong, Annpey;
Lin, Jianxin;
Cater, Nilo B.;
Pratley, Richard E.

Publication type:

Article

Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1829, doi. 10.1111/dom.14769

By:

Segar, Matthew W.;
Kolkailah, Ahmed A.;
Frederich, Robert;
Pong, Annpey;
Cannon, Christopher P.;
Cosentino, Francesco;
Dagogo‐Jack, Samuel;
McGuire, Darren K.;
Pratley, Richard E.;
Liu, Chih‐Chin;
Maldonado, Mario;
Liu, Jie;
Cater, Nilo B.;
Pandey, Ambarish;
Cherney, David Z. I.

Publication type:

Article

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691

By:

Dagogo‐Jack, Samuel;
Cannon, Christopher P.;
Cherney, David Z. I.;
Cosentino, Francesco;
Liu, Jie;
Pong, Annpey;
Gantz, Ira;
Frederich, Robert;
Mancuso, James P.;
Pratley, Richard E.

Publication type:

Article

The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1114, doi. 10.1111/dom.14677

By:

Cherney, David Z. I.;
Cosentino, Francesco;
Pratley, Richard E.;
Dagogo‐Jack, Samuel;
Frederich, Robert;
Maldonado, Mario;
Liu, Jie;
Pong, Annpey;
Liu, Chih‐Chin;
Cannon, Christopher P.

Publication type:

Article

Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2276, doi. 10.1111/dom.14150

By:

Pratley, Richard;
Dagogo‐Jack, Samuel;
Charbonnel, Bernard;
Patel, Shrita;
Hickman, Anne;
Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Ellison, Misoo C.;
Huyck, Susan;
Gantz, Ira;
Terra, Steven G.

Publication type:

Article

The effects of ertugliflozin on β‐cell function: Pooled analysis from four phase 3 randomized controlled studies.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2267, doi. 10.1111/dom.14149

By:

Gallo, Silvina;
Raji, Annaswamy;
Calle, Roberto A.;
Pong, Annpey;
Meyer, Christian

Publication type:

Article

Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 574, doi. 10.1111/dom.13931

By:

Liu, Jie;
Patel, Shrita;
Cater, Nilo B.;
Wu, Larry;
Huyck, Susan;
Terra, Steven G.;
Hickman, Anne;
Darekar, Amanda;
Pong, Annpey;
Gantz, Ira

Publication type:

Article

Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials.

Published in:

Diabetes Therapy, 2020, v. 11, n. 8, p. 1849, doi. 10.1007/s13300-020-00867-1

By:

Gallo, Silvina;
Calle, Roberto A.;
Terra, Steven G.;
Pong, Annpey;
Tarasenko, Lisa;
Raji, Annaswamy

Publication type:

Article

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in paediatric subjects: An analysis by age group.

Published in:

2018

By:

Kang, Hyoung Jin;
Loftus, Susan;
DiCristina, Cara;
Green, Stuart;
Pong, Annpey;
Zwaan, Christian Michel

Publication type:

journal article

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from a randomized clinical trial of response in subjects by cancer type.

Published in:

2020

By:

Weinstein, Cindy;
Jordan, Karin;
Green, Stuart;
Khanani, Saleem;
Beckford-Brathwaite, Elizabeth;
Vallejos, Waldimir;
Pong, Annpey;
Noga, Stephen J.;
Rapoport, Bernardo L.

Publication type:

journal article